Prostate Cancer
Milestones in the progression of cancer can define treatment and assess outcome
Published in Cancer Weekly, April 1st, 2003
According to recent research from the United States, "The development and progression of a prostate carcinoma from prediagnosis to death can be characterized as a series of clinical states."
"The states are milestones that can be used to assess prognosis, define therapeutic objectives, and assess outcomes. The antitumor effects of hormone therapies and cytotoxic agents in patients with prostate carcinoma are placed in context along with the bidrectional tumor-host interactions that contribute to the growth and resistance of osseous lesions. Identifying the factors that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-04-01)
More Articles from Cancer Weekly
- Breast Cancer Diagnosis
NIST, UW-Madison research may lead to new breast cancer detection methods - Cancer Metastasis
Thrombin generation correlates with biomarkers in advanced prostate cancer - Bone Cancer
Pulmonary metastasis can arise after surgery for osteosarcoma - Cancer Markers
Disruption of the HIC1 gene may predispose mice to gender-specific malignancy - Colon Cancer Screening
Potential blood test could predict risk - Rhabdomyosarcoma
Gene that drives apoptosis also plays key role in development of skeletal muscle - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
